Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections

published online 19 October 2009.

We compared costs, length of stay, and mortality between adults with Candida albicans and Candida glabrata bloodstream infections. Early evidence of C glabrata, as defined by a positive culture within 2 days of admission, was associated with higher costs ($56,026 vs $32,810; P = .04) and longer hospital stays (19.7 vs 14.5 days; P = .05) compared with early evidence of C albicans. Mortality was similar between the groups.

Key Words: Candida albicans, Candida glabrata, cross infection, health care costs, length of stay, mortality

a Department of Pediatrics, Duke University School of Medicine, Durham, NC

b Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC

c Astellas Pharma US, Deerfield, IL

d Duke Clinical Research Institute, Durham, NC

e Department of Medicine, Duke University School of Medicine, Durham, NC

Address correspondence to Shelby D. Reed, PhD, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715.

PII: S0196-6553(09)00755-X

doi:10.1016/j.ajic.2009.06.014

21 of 25